Aurion Biotech
  • Our Focus
  • Products
  • About Us
  • Resources
  • News
  • Careers
  • Contact
  • Summer Solstice or Mid-year Madness? 

    As others have said both are valid and will do the trick. I’m not 100% convinced that they are identical though. If you have some style cascading going on then they could in theory produce different results since they are effectively override.

  • Aurion Biotech Appoints Dr. Michael Goldstein as President and Chief Medical Officer

    As others have said both are valid and will do the trick. I’m not 100% convinced that they are identical though. If you have some style cascading going on then they could in theory produce different results since they are effectively override.

  • Aurion Biotech Wins ASCRS Eyecelerator Award

    As others have said both are valid and will do the trick. I’m not 100% convinced that they are identical though. If you have some style cascading going on then they could in theory produce different results since they are effectively override.

Advanced Therapies for Ocular Diseases

We are a clinical-stage biotech company. We aim to restore vision to all who need it by developing a platform of innovative, accessible, and effective advanced therapies. Our first candidate is a patented cell therapy treatment for corneal endothelial disease.

    PreviousNext
    Our Focus News Careers

    © 2021 Aurion Biotechnologies

     

    • Terms
    • Privacy Policy
    • Contact
    Twitter icon. Facebook icon. LinkedIn icon.